Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
461 - 470 of 892 results
  • Abstract
    Behavioural phenotyping of mice lacking CB1 cannabinoid receptors in neurons expressing D1 dopamine receptors in models of anxiety and motor activity
    Several pieces of evidence suggest that the endocannabinoids and dopamine are neurotransmitters sharing physiological roles in the control of locomotion and emotional states. In order to further investigate the functional interactions between these neur...
    Nov 6, 2007
  • Abstract
    Effects of ondansetron and URB597 on the expression of lithium-induced anticipatory nausea in rats
    Cancer patients undergoing chemotherapy treatments often report anticipatory nausea (AN) when they are re-exposed to contextual cues previously paired with treatment. AN is resistant to treatment with classical anti-emetic drugs such as ondansetron (OND...
    Nov 4, 2007
  • Abstract
    Differential behavioral and neurochemical effects of low dose nicotine treatment in adolescent and adult rats
    Epidemiological studies have established that drug use in adolescence is initiated with tobacco and alcohol and progresses to marijuana and other illicit drugs. These findings have led to the hypothesis that alcohol and tobacco are ‘gateway’ drugs that ...
    Nov 4, 2007
  • Abstract
    Rimonabant-resistant tetrad effects of improgan in mice: antagonism by CC12
    Improgan (a derivative of cimetidine with an unknown mechanism of action) produces antinociception which is reversed by the CB1 receptor antagonist rimonabant and is reduced in THC-tolerant animals, yet improgan has no affinity for the CB1 receptor (Eur...
    Nov 7, 2007
  • Abstract
    Age and diet-related changes of cannabinoid 1 receptor (cb1r) binding in obese (fa/fa) and lean adult zucker rats
    The CB1R and the Endocannabinoid System (EC) has been shown to play a fundamental role in diet-induced obesity. Δ9 -THC, and the endogenous cannabinoid, (AEA) (N-Arachidonoylethanolamide), have both been shown to stimulate food intake by activating the ...
    Nov 6, 2007
  • Abstract
    Distribution and localization of cannabinoid receptor type 1 system components in the nucleus accumbens core and shell of vervet monkeys
    Dopamine (DA) release onto the nucleus accumbens (NAc) is central to the reward circuit, the dysregulation of which plays a role in addiction. The NAc can be anatomically divided into a core and shell. Both regions receive DA projections from the ventra...
    Nov 15, 2017
  • Afferent-Specific AMPA Receptor Subunit Composition and Regulation of Synaptic Plasticity in Midbrain Dopamine Neurons by Abused Drugs | Journal of Neuroscience
    Ventral tegmental area (VTA) dopamine (DA) neurons play a pivotal role in processing reward-related information and are involved in drug addiction and mental illness in humans. Information is conveyed to the VTA in large part by glutamatergic afferents that arise in various brain nuclei, including the pedunculopontine nucleus (PPN). Using a unique rat brain slice preparation, we found that PPN stimulation activates afferents targeting GluR2-containing AMPA receptors (AMPAR) on VTA DA neurons, and these afferents did not exhibit long-term depression (LTD). In contrast, activation of glutamate afferents onto the same DA neurons via stimulation within the VTA evoked EPSCs mediated by GluR2-lacking AMPARs that demonstrated LTD or EPSCs mediated by GluR2-containing AMPA receptors that did not express LTD. Twenty-four hours after single cocaine injections to rats, GluR2-lacking AMPARs were increased at both PPN and local VTA projections, and this permitted LTD expression in both pathways. Single injections with ...
    Jun 9, 2010 Cameron H. Good
  • Abstract
    Analysis of ack1 interacting proteins
    Ack1 correspond to a new subfamily of tyrosine kinases having several protein-protein interaction domains: an SH3 domain, a region able to interact with Cdc42 (Cbd domains: Cdc42 binding domain) and several proline riche regions. In previous work we hav...
    Nov 3, 2007
  • Abstract
    VDM-11, an endocannabinoid reuptake inhibitor, improves amnesia induced by â-amyloid fragment 1-42.
    There is evidence that i.c.v. infusion of the â-amyloid (Aâ) 1-42 peptide fragment (BAP 1-42) may cause brain dysfunction as evidenced by neurodegeneration and impairment of learning and memory, typical symptoms of Alzheimer’s disease. Neurodegeneration affects subcortical nuclei involved in cognitive behavior and disrupt cholinergic neurotransmission in these nuclei. Endogenous cannabinoids decrease brain ACh levels and may induce a deficit of memory capacity. These effects are mediated by the activation of CB1 cannabinoid receptors. In fact, administration of the selective CB1 cannabinoid receptor antagonist, SR141716A, reversed in mice the cognitive impairment induced by cannabinoids, such as marijuana and its active ingredient Ä9 – tetrahydrocannabinol, or endogenous cannabinoids, such as anandamide. SR141716A also counteracted the amnesia induced by BAP 1-42 in the passive avoidance paradigm. It is likely that a direct correlation exists between the amnesic effect induced by Aâ and cerebral CB1 action...
    Oct 26, 2004
  • Abstract
    Modulation of natural reward circuitry.
    Feeding behavior is one of most important motivated behaviors and the most potent drive for feeding is its reward nature in human and mammal. The lateral hypothalamus is critical for regulation of feeding behavior and is considered an important structure for the brain reward circuitry. Synaptic interactions within the hypothalamus per se as well as the activity of the feeding-related projection neurons in the lateral hypothalamus are subject to extensive modulation. Despite the well-known physiological effects of nicotine and delta9(-)-tetrahydrocannabinol (THC) administered exogenously, relatively little is known of the hypothalamic actions of their endogenous counterparts. Our present study provided a neurophysiological analysis of the modulation of the excitability of melanin-concentrating hormone (MCH) synthesizing neurons in the lateral hypothalamus (LH) implicated in natural reward behavior. We first identified MCH neurons based on the electrophysiological profile. MCH neurons showed a strong accommo...
    Nov 9, 2003
  • Previous
  • 45
  • 46
  • 47
  • 48
  • 49
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience